> Western Medicines > Pembrolizumab

Pembrolizumab

Used for: Treatment of head and neck cancer, Treatment of non-small cell lung cancer (NSCLC), Treatment of oesophageal cancer, Treatment of urothelial carcinoma, Treatment of breast cancer, Treatment of gastric cancer, Treatment of endometrial carcinoma, Treatment of melanoma, Treatment of liver cancer, Treatment of Hodgkin lymphoma, Treatment of skin cancer, Treatment of kidney cancer, Targeted cancer therapy, Treatment of cervical cancer
Chinese name:

What is Pembrolizumab for?

Pembrolizumab, which is a monoclonal antibody, belongs to a class of medications called immune checkpoint inhibitors. It works by blocking a certain protein in the body to boost your immune system for attacking cancer cells. It is a type of targeted therapy to treat many types of cancer, including but not limited to breast cancer, cervical cancer, oesophageal cancer, endometrial cancer, gastric cancer, head and neck cancer, liver cancer, Hodgkin lymphoma, melanoma, skin cancer, lung cancer, kidney cancer, and urothelial cancer.

How to use it?

Pembrolizumab is injected intravenously. The usual dose is either 200 mg every 3 weeks OR 400 mg every 6 weeks used as a monotherapy or combination therapy. The usage may be adjusted based on clinical judgement.

What are the side effects of Pembrolizumab?

Common side effects of Pembrolizumab include fatigue, musculoskeletal pain, decreased appetite, diarrhea, nausea, rash, fever, cough, dyspnea, constipation, pain, and abdominal pain.

Who should not take Pembrolizumab?

  • People who are allergic to Pembrolizumab or any component of the formulation.

Pharmacist Tips:

  • Use effective contraception to avoid pregnancy during therapy and for at least 4 months after the last dose.
  • Tell your doctor if you have had an organ transplant or stem cell transplant before using this drug.
  • This drug may cause immune-related adverse effects. Seek medical help immediately if you have symptoms such as pneumonitis, colitis, hepatitis, and dermatologic adverse reactions (e.g. rash, vitiligo).

Common dosing schedule:
N/A

 

Some common medications Pembrolizumab may interact with:

  • No significant drug interactions.

Where to buy Pembrolizumab in Hong Kong?

In Hong Kong, Pembrolizumab is a prescription only medicine, and requires a prescription from a doctor to be purchased in a pharmacy. It can also be obtained from doctors. To find a pharmacy near you, refer to the list of pharmacies (“Authorized Sellers of Poisons”) from the Hong Kong Department of Health.

 

For more information about drug names and ingredients, you can visit Hong Kong’s Drug Office at https://www.drugoffice.gov.hk

Need more information?

For detailed information about the use of Pembrolizumab in children, pregnancy and breastfeeding, and for questions about drug interactions, please check with your pharmacist or doctor.

Disclaimer: our goal is to provide you with the most relevant drug information and common dosage for Hong Kong. This information does not constitute medical advice. For specific treatment recommendations and advice, always discuss with your doctor or pharmacist, and follow the instructions included with your specific medicine.

Brands in Hong Kong
Keytruda
Available dosage
  • 100mg/4ml (Injections)
Drug class
Antineoplastics
Sub class
Immune Checkpoint Inhibitors, Biologics, Monoclonal Antibodies
Other drugs in same class
Bevacizumab
Used for: Targeted cancer therapy, Treatment of cervical cancer, Treatment of liver cancer, Treatment of non-small cell lung cancer (NSCLC), Treatment of colorectal cancer, Treatment of ovarian cancer, Treatment of kidney cancer
Chinese name:
Idarucizumab
Used for: Reversal of dabigatran
Chinese name:
Evolocumab
Used for: Hyperlipidemia, Prevention of cardiovascular events
Chinese name: